Role of Serum Growth Factor and Inflammatory Markers in Predicting the Progression of Oral Squamous Cell Carcinoma: A Clinical Study
Tejal Patil, Jasmine Kalsi, Mukesh Kumar, Rahul VC Tiwari, Ambili Remesh, Unni J Appilly · 2026
Read Role of Serum Growth Factor and Inflammatory Markers in Predicting the Progression of Oral Squamous Cell Carcinoma: A Clinical Study by Tejal Patil, Jasmine Kalsi, Mukesh Kumar, Rahul VC Tiwari, Ambili Remesh, Unni J Appilly (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13292104.txt.
Description
Tejal Patil and co-authors run a 2026 prospective study asking whether blood levels of growth and inflammation markers can flag oral cancer patients headed for recurrence. They followed 120 people with confirmed oral squamous cell carcinoma. Blood drawn at diagnosis, six months, and twelve months was tested for EGFR, interleukin-6, and TNF-alpha.
Thirty-four patients, 28.33 percent of the cohort, saw their cancer return, and their starting marker levels were far higher than those who stayed clear. The gap held at later draws too. Marker levels also rose alongside tumor size, overall stage, and lymph node spread. In adjusted analysis, all three baseline markers independently predicted recurrence. The authors suggest serial blood testing could sharpen follow-up for this common, relapse-prone cancer.
Catalog record
| CREATOR | Tejal Patil, Jasmine Kalsi, Mukesh Kumar, Rahul VC Tiwari, Ambili Remesh, Unni J Appilly |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25092 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |